Who owns Mission Therapeutics?

Mission Therapeutics is currently owned by Sofinnova Partners, through Sofinnova Capital IX, since 2019.

When did Sofinnova Partners acquire Mission Therapeutics?

Sofinnova Partners acquired Mission Therapeutics in 2019 (active for 7 years).

Home/Companies/Biotech/Mission Therapeutics

Mission Therapeutics

Biotech·

UK·Active·7yr hold

Mission Therapeutics is a healthcare / biotech company, headquartered in United Kingdom.

Entry

2019

Hold

7yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQUnited Kingdom

SectorHealthcare / Biotech

UK company developing ubiquitin pathway inhibitors including deubiquitylase inhibitors for mitochondrial health and neurodegeneration.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Capital IX

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings